Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
Benallegue, N., Rollot, F., Wiertlewski, S., Casey, R., Debouverie, M., Kerbrat, A., De Seze, J., Ciron, J., Ruet, A., Labauge, P., et al. (2024). JAMA Neurol (81). p.273–282

The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics
Vukusic, S., Bourre, B., Casey, R., Deiva, K., Guennoc, A.-M., Lebrun-Frenay, C., Leray, E., Rollot, F., Benyahya, L., Girod, C., et al. (2024). Mult Scler (30). p.216–226

Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks
Januel, E., Brochard, V., Le Guennec, L., Maillart, E., Louapre, C., Lubetzki, C., Weiss, N., Demeret, S., and Papeix, C. (2024). Ann Intensive Care (14). p.4